Adenosine receptors and Parkinson's disease /

This book is the first definitive overview on adenosine receptor antagonists and their application to the treatment of Parkinson's Disease. The effect of these novel non-dopamine drugs on vitro and in vivo systems clearly shows their potential for the treatment of this debilitating disease. Thi...

Full description

Saved in:
Bibliographic Details
Corporate Authors: Elsevier Science & Technology.
Group Author: Kase, Hiroshi. (Editor); Richardson, Peter J. (Editor); Jenner, Peter, 1946- (Editor)
Published: Academic Press,
Publisher Address: San Diego, CA :
Publication Dates: 2000.
Literature type: eBook
Language: English
Series: Pure and applied mathematics series ; v. 90
Subjects:
Online Access: http://www.sciencedirect.com/science/book/9780124004054
Summary: This book is the first definitive overview on adenosine receptor antagonists and their application to the treatment of Parkinson's Disease. The effect of these novel non-dopamine drugs on vitro and in vivo systems clearly shows their potential for the treatment of this debilitating disease. This book covers how the Parkinson's disease antagonist drug, A2A, has been researched, developed, and tested. It is an essential book for researchers interested in the basal ganglia, purine biology, and Parkinson's Disease. Key Features * Discusses the discovery and development of a novel non-dopaminomimetic agent for Parkinson's disease * Provides the first definitive overview of adenosine antagonists and their role in the treatment of Parkinson's disease * Presents a new mechanism of action of adenosine A2A receptor antagonists in motor function Proposes a hypothesis of adenosine A2A receptor function in the striatum * Comprehensive overview of adenosine, its receptor subtypes, their antagonists/agonists from biochemistry, molecular biology, medicinal chemistry, physiology, pharmacology, and neurochemistry viewpoints.
Carrier Form: 1 online resource (xviii, 275 pages [1] color plate) : illustrations.
Bibliography: Includes bibliographical references and index.
ISBN: 9780124004054
0124004059
9781435605138
1435605136
0080525954
9780080525952
128105383X
9781281053831
Index Number: RC382
CLC: R742.5
Contents: Introductory Remarks: Adenosine A2A Receptor Antagonists: A Novel Approach to the Treatment of Parkinson's Disease. /
Localisation of Adenosine Receptors in Brain and Periphery. /
Medicinal Chemistry of Adenosine Receptors in Brain and Periphery. /
Overview of the Physiology and Pharmacology of Adenosine in the Peripheral System. /
Biochemical Characterization of Adenosine Agonists and Antagonists. /
Physiology of Adenosine Receptors in the Striatum: Regulation of Striatal Projection Neurons. /
The Regulation of Neurotransmitter Release in Basal Ganglia by Adenosine Receptor Agonists and Antagonists in Vitro and in Vivo. /
Control of Gene Expression in the Basal Ganglia Induced by Adenosine Receptors. /
Knockout Mice in the Study of Dopaminergic Diseases. /
Effects of Adenosine Receptors Experimental Models of Cognition and Motor Behaviour. /
Actions of Adenosine Antagonists in a Primate Model of Parkinson's Disease. /
Selective Adenosine A2A Receptor Antagonism as an Alternative Therapy for Parkinson's Disease: A Study in Nonhuman Primates. /
Neurobiology of Adenosine Receptors: Adenosine and its Metabolites in Movement Disorders. /